GeneDx Holdings (WGS) Hit with Securities Class Action Following 49% Stock Collapse — HBSS
Hagens Berman announced an investigation into a securities class action against GeneDx Holdings, alleging the company misled investors regarding the efficiency and profitability of the Fabric Genomics acquisition. The lawsuit follows a 49% stock collapse on May 5, 2026, after the company reported a $31.2 million impairment charge and slashed full-year guidance by 12%.
Key figures
- Stock drop
- 49%
- Guidance cut
- 12%
- Revenue miss
- $2.5 million
- Impairment charge
- $31.2 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.